IRIS
FRANZONE, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.960
EU - Europa 2.976
NA - Nord America 2.464
SA - Sud America 558
AF - Africa 132
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.100
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.356
SG - Singapore 2.122
RU - Federazione Russa 1.595
CN - Cina 979
IT - Italia 544
BR - Brasile 443
HK - Hong Kong 351
VN - Vietnam 264
NL - Olanda 183
DE - Germania 167
GB - Regno Unito 91
FI - Finlandia 88
FR - Francia 68
IE - Irlanda 56
CI - Costa d'Avorio 50
AR - Argentina 49
CA - Canada 47
IN - India 47
KR - Corea 47
MX - Messico 36
ZA - Sudafrica 31
AT - Austria 28
BD - Bangladesh 25
PL - Polonia 25
EC - Ecuador 22
UA - Ucraina 21
ID - Indonesia 20
SE - Svezia 19
ES - Italia 18
CZ - Repubblica Ceca 16
JP - Giappone 16
CH - Svizzera 12
KE - Kenya 10
MA - Marocco 10
PK - Pakistan 10
IQ - Iraq 9
TR - Turchia 9
AZ - Azerbaigian 8
BE - Belgio 8
CO - Colombia 8
JO - Giordania 8
LT - Lituania 8
PY - Paraguay 8
CL - Cile 7
PE - Perù 7
AE - Emirati Arabi Uniti 6
UZ - Uzbekistan 6
EG - Egitto 5
IR - Iran 5
VE - Venezuela 5
AU - Australia 4
BO - Bolivia 4
HN - Honduras 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PA - Panama 4
PT - Portogallo 4
RS - Serbia 4
UY - Uruguay 4
AL - Albania 3
BG - Bulgaria 3
MK - Macedonia 3
NG - Nigeria 3
NP - Nepal 3
SN - Senegal 3
AO - Angola 2
BF - Burkina Faso 2
BS - Bahamas 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GT - Guatemala 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
LB - Libano 2
ME - Montenegro 2
MG - Madagascar 2
MY - Malesia 2
NI - Nicaragua 2
PH - Filippine 2
PS - Palestinian Territory 2
RO - Romania 2
SA - Arabia Saudita 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DZ - Algeria 1
GH - Ghana 1
GN - Guinea 1
HR - Croazia 1
HT - Haiti 1
Totale 10.084
Salva come PNG Salva come JPEG
Città #
Singapore 989
Moscow 370
Hong Kong 351
Ashburn 286
Beijing 264
Hefei 244
Chandler 186
Amsterdam 157
Naples 146
Millbury 117
Santa Clara 117
Ho Chi Minh City 106
Los Angeles 99
Nanjing 86
Princeton 81
Munich 68
Redondo Beach 60
Napoli 57
Boston 53
Des Moines 51
Hanoi 50
São Paulo 46
New York 45
Seoul 45
Buffalo 42
The Dalles 39
Dallas 31
Wilmington 29
Nanchang 25
Nuremberg 24
Ottawa 24
Frankfurt am Main 23
Denver 20
Orem 20
Helsinki 19
Warsaw 18
Hebei 17
Afragola 16
Lawrence 16
London 16
Mexico City 16
Phoenix 16
Atlanta 15
Chicago 15
Rome 15
Shenyang 15
Stockholm 15
Haiphong 14
Poplar 14
Rio de Janeiro 14
Seattle 14
Tianjin 14
Turku 14
Changsha 13
Dong Ket 13
Tokyo 13
Vienna 13
Washington 13
Brno 12
Chennai 12
Johannesburg 12
Bern 11
Brasília 11
Brooklyn 11
Guayaquil 11
Jacksonville 11
Kunming 11
Lappeenranta 11
Milan 11
San Francisco 11
Council Bluffs 10
Buenos Aires 9
Jiaxing 9
Nairobi 9
Torre del Greco 9
Augusta 8
Baku 8
Belo Horizonte 8
Da Nang 8
Houston 8
Kronberg 8
Manchester 8
Montreal 8
San Giuseppe Vesuviano 8
Shanghai 8
Bexley 7
Düsseldorf 7
Norwalk 7
Amman 6
Biên Hòa 6
Curitiba 6
Dhaka 6
Mumbai 6
Pune 6
Querétaro 6
Recife 6
Ribeirão Preto 6
Roubaix 6
San Mateo 6
Tashkent 6
Totale 5.063
Salva come PNG Salva come JPEG
Nome #
Akap1 Regulates Vascular Function and Endothelial Cells Behavior 151
Loss of Akap1 exacerbates pressure overload-induced cardiac hypertrophy and heart failure 132
Dermcidin: a skeletal muscle myokine modulating cardiomyocyte survival and infarct size after coronary artery ligation 131
Infectious endocarditis after transcatheter aortic valve implantation in a patient on oral therapy with glucocorticoids 127
IDENTIFICAZIONE PROTEOMICA DI UN NUOVO FATTORE COINVOLTO NELLA MODULAZIONE MOLECOLARE DEL RIMODELLAMENTO CARDIACO POST-ISCHEMICO NELL'ISCHEMIA CRONICA DEGLI ARTI INFERIORI. 125
Renal sympathetic-nerve ablation for uncontrolled hypertension in a patient with single-kidney autosomal dominant polycystic kidney disease. 121
Effects of Successful Percutaneous Lower Extremity Revascularization on Cardiovascular Outcome in Patients with Peripheral Arterial Disease 116
ADDED Index or percentage diameter of residual coronary stenosis to risk-stratify patients presenting with STEMI 116
RUOLO DELL’UNCOUPLING PROTEIN 3 IN CONDIZIONI IPOSSICO-ISCHEMICHE 115
Ankle/brachial index to everyone. 115
Adverse Post-Ischemic Cardiac Remodeling in Chronic Hindlimb Ischemia: Proteomic Identification of a Novel Molecular Mechanism 114
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry 112
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial 110
Predictors of adherence to composite therapy after acute coronary syndromes 110
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention 108
L’IMPIANTO DI STENT NELLE ARTERIE DEGLI ARTI INFERIORI RIDUCE IL RISCHIO CARDIOVASCOLARE IN PAZIENTI CON ATEROSCLEROSI PLURIDISTRETTUALE. 108
Cardioprotective role of Urotensin (UT II)- mediated transactivation of the EGFR. 107
Extent of cardiac damage and mortality in patients undergoing transcatheter aortic valve implantation 107
Meta-Analysis of Mortality Outcomes and Mitral Regurgitation Evolution in 4,839 Patients Having Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis. 106
Incidence, predictors, and prognostic impact of temporary left bundle branch block after transcatheter aortic valve replacement 105
ATHERECTOMY AS ALTERNATIVE ENDOVASCULAR THERAPY FOR INFRAINGUINAL ARTERY DISEASE. 103
Biological effects of statins in atherosclerosis 103
Contemporary use and results of intra-aortic balloon pump counterpulsation. 103
Echocardiographic Evaluation of Aortic Stenosis: A Comprehensive Review 101
Il secondo messaggero cAMP e la regolazione della funzione cardiaca: ruolo dell'adenilato ciclasi. 101
Arterial hypertension in aortic valve stenosis: A critical update 101
Left ventricular diastolic gradient in hypertrophic cardiomyopathy 100
CT Coronary Angiography: Technical Approach and Atherosclerotic Plaque Characterization 99
Hemodynamic Performance of Transcatheter Aortic Valves: A Comprehensive Review 99
Novel Molecular Approaches in Heart Failure: Seven Trans-Membrane Receptors Signaling in the Heart and Circulating Blood Leukocytes 99
Molecular modulation of post-ischemic cardiac remodeling by hindlimb ischemia 99
Impact of COVID-19 pandemic on timing and early clinical outcomes of transcatheter aortic valve implantation 98
Is There Still a Role for Invasive Assessment of Aortic Gradient? 97
Myocardial mass affects diagnostic performance of non-hyperemic pressure-derived indexes in the assessment of coronary stenosis 97
Induction of mitogen activated protein kinases in response to pressure overload: a novel possible biomarker for uncontrolled human hypertension. 97
Circulating miR-29a, Among Other Upregulated microRNAs, is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients with Hypertrophic Cardiomyopathy. 97
Effects of Carvedilol Versus Metoprolol on Platelet Aggregation in Patients With Acute Coronary Syndrome: The PLATE-BLOCK Study 97
Echocardiographic Evaluation after Transcatheter Aortic Valve Implantation: A Comprehensive Review 96
Changes and prognostic impact of noninvasive myocardial work indices in patients undergoing transcatheter aortic valve implantation 94
Il ruolo del danno ischemico remoto permanente sul rimodellamento ventricolare post-IMA 94
Coronary angioplasty with stenting for acute coronary syndrome in patients with isolated single coronary artery: a report of two cases 94
Rotational atherectomy for the treatment of isolated femoral artery traumatic lesion: A case report 94
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 93
Il ruolo del danno ischemico remoto permanente sul rimodellamento ventricolare post-IMA 92
Evidence Supporting Criteria for Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Intervention 91
Management of Intraventricular Gradient in Patients With Aortic Stenosis 91
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 91
Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis 91
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions 90
Management of Non-Culprit Lesions in STEMI Patients with Multivessel Disease 90
Angiographic complexity of coronary artery disease according to syntax score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: A substudy of the bioscience trial 90
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial 90
Myocardial Injury After Transcatheter Aortic Valve Replacement According to VARC-3 Criteria 88
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation 88
Cardiovascular effects of treadmill exercise in physiological and pathological preclinical settings. 88
The circulating level of FABP3is an indirect biomarker of microRNA-1. 88
Effects of pressure unloading on mitogen-activated protein kinases in peripheral blood mononuclear cells of patients undergoing trans-catheter aortic valve implantation. 87
Correction to: Acute advanced aortic stenosis 86
Gβγ-dependent transactivation of the epidermal growth factor receptor by the Urotensin-II receptor. 86
Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicenter Italian experience 85
Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII study 83
Bioabsorbable drug-eluting vascular scaffold for the treatment of coronary in-stent restenosis: A two center registry 83
EGFR Trans-activation by Urotensin II Receptor is Mediated by Beta-arrestin Recruitment and Confers Cardioprotection in Pressure Overload-induced Cardiac Hypertrophy. 83
Effects of Guiding Catheter Disengagement on Resting Indexes for the Assessment of Coronary Artery Stenoses 82
Sex and gender specific pitfalls and challenges in cardiac rehabilitation: a working hypothesis towards better inclusivity in cardiac rehabilitation programmes. 82
A Comparison Between Radial Artery Compression Devices for Patent Hemostasis After Transradial Percutaneous Interventions 82
Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure 81
From biodegradable polymers to bioresorbable vascular scaffolds: available evidence in the current era of new-generation DES 80
A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study 80
Venous Thromboembolism and Cancer: A Comprehensive Review from Pathophysiology to Novel Treatment 79
De-Activation of Mitogen-Activated Protein Kinases in Peripheral Blood Mononuclear Cells of Patients Undergoing Trans-Catheter Aortic Valve Implantation. 79
Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients with Acute ST-Segment Elevation Myocardial Infarction: Insights from the 2-Year Follow-Up of the BIOSCIENCE Trial 78
One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients 77
Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI 76
Mortality after Bleeding versus Myocardial Infarction in Coronary Artery Disease: A Systematic Review and Meta-Analysis 76
Acute advanced aortic stenosis 76
Stroke volume index and transvalvular flow rate trajectories in severe aortic stenosis treated with TAVR 75
Renin-angiotensin system inhibitors reduce cardiovascular mortality in hypertensive patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: insights from the EffecTAVI registry 69
Endovascular repair for isolated iliac artery aneurysms: case report and review of the current literature. 67
Coronary artery disease and myocardial revascularization in patients undergoing transcatheter aortic valve replacement 66
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent for percutaneous coronary revascularization: 2-year results of the BIOSCIENCE trial 64
Use of the dual-antiplatelet therapy score to guide treatment duration after percutaneous coronary intervention 62
Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes 61
Double layered stents for carotid angioplasty: A meta-analysis of available clinical data 60
Pharmacodynamic effects of cangrelor in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention: the POMPEII Registry 59
Transcatheter Aortic Valve Replacement for the Treatment of Pure Native Aortic Valve Regurgitation: A Systematic Review 59
Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection 59
Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: Prespecified subgroup analysis of the BIOSCIENCE trial 57
RUOLO PROTETTIVO DELL'UNCOUPLING PROTEIN 3 (UCP3) NELLA MALATTIA ISCHEMICA. 56
Comparative effectiveness and safety of new-generation versus early-generation drug-eluting stents according to complexity of coronary artery disease: A patient-level pooled analysis of 6,081 patients 56
The Conundrum of Permanent Pacemaker Implantation after Transcatheter Aortic Valve Implantation 56
Stent implantation in the arteries of the lower limbs reduces cardiovascular risk in peripheral arterial disease. 55
SAFETY AND EFFICACY OF OUBACK CATHETER-ASSISTED SUBINTIMAL RECANALIZATION OF TOTAL CHRONIC ILIAC ARTERY OCCLUSION. 55
Nuovi concetti nella segnalazione beta-adrenergica: prospettive terapeutiche per lo scompenso cardiaco.. [Novel concepts in beta-adrenergic receptor signaling: therapeutic options for heart failure]. 55
Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload. 54
La modulazione molecolare del rimodellamento cardiaco post-ischemico nell'ischemia cronica degli arti inferiori. 53
Rationale and Design of the PARTHENOPE Trial: A Two-by-Two Factorial Comparison of Polymer-Free vs. Biodegradable-Polymer Drug-Eluting Stents and Personalized vs. Standard Duration of Dual Antiplatelet Therapy in All-Comers Undergoing PCI 50
Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration: A Pre-Specified Analysis From the PRODIGY Trial 50
Prognostic Relevance of Left Ventricular Myocardial Performance After Transcatheter Aortic Valve Replacement 49
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: The GLOBAL LEADERS Adjudication Sub-StudY (GLASSY) 49
Totale 8.777
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.364
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021122 0 0 0 0 0 22 3 11 32 1 40 13
2021/2022472 11 0 2 1 13 9 4 24 74 31 80 223
2022/2023648 99 43 25 27 59 54 11 34 83 157 38 18
2023/2024665 20 94 90 62 35 71 25 66 24 17 94 67
2024/20253.510 153 147 16 36 87 154 391 230 297 369 1.337 293
2025/20264.268 723 579 742 738 1.196 290 0 0 0 0 0 0
Totale 10.329